Home » Healthcare » Pharmaceuticals » In-Vitro Fertilization Market

In-Vitro Fertilization Market By Instrument (Disposable Devices, Culture Media and Capital Equipment), By Type (Fresh Donor, Frozen Donor, Fresh Non-Donor and Frozen Non-Donor), By End User (Fertility Clinics and Hospitals) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 6406 | Report Format : PDF

Industry Outlook

The in-vitro fertilization market is expected to grow from $15,604.7 million in 2017 to $36,854.0 million in 2026, with a compounded annual growth rate of 10.1% projected from 2018 to 2026. A significant increase in couples having children later in life, as a result of increased preference for professional careers and technological advancements in IVF treatment, will drive market growth in the coming years.

Increased research activities to improve culture media and sperm preservation capabilities without sacrificing quality will drive culture media market growth.

Culture media currently have the largest market share among in vitro fertilization instruments. Increased research activities in improving culture media and the ability to preserve sperm without losing quality are major contributing factors. Increasing demand for egg processing media and the establishment of numerous egg cryobanks further bolster the market’s growth for culture media. Strict regulatory mandates and the need to maintain optimum sterile conditions will propel the market growth of disposable devices at a faster rate.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Frozen non-donor will be the fastest-growing segment due to an excellent live birth rate, better implementation, and a lower miscarriage rate.

Fresh non-donor is currently reigning in the type segment for the in-vitro fertilization market. The high success rate on the first try is the primary reason for its impressive market growth. Frozen non-donor will showcase outstanding growth in the next few years on account of an excellent live birth rate, better implementation, reduced cases of ectopic pregnancy, and a lower miscarriage rate.

The availability of sophisticated equipment and the significant rise in couples opting for assisted reproductive technology (ART) drive the market growth for fertility clinics.

Fertility clinics are dominating the end-user segment of the in-vitro fertilization market. The fertility clinic market is growing due to an increase in the number of couples opting for ART treatments such as intracytoplasmic sperm injection (ICSI) and gamete intrafallopian transfer (GIFT). Hospitals are showcasing steady growth on account of enhanced government funding to provide IVF treatment to poor families and rising public health awareness pertaining to infertility treatment.

The rising prevalence of infertility and the adoption of sophisticated IVF technology drive market growth in the North American region.

North America is responsible for 35% of market growth and is the leading regional segment for the in-vitro fertilization market. The rising prevalence of infertility is one of the contributing factors to its market dominance. As per the research findings of the American Society for Reproductive Medicine (ASRM), approximately 6.7 million women are suffering from infertility in the United States, which represents 11.0% of the reproductive population. Europe has a 30% market share due to government initiatives that provide financial incentives for gametes freezing and IVF cycles. Asia Pacific represents 20% market share and will capture the market in the next few years on account of the presence of a large target population, the adoption of sophisticated technology, and low treatment costs in comparison to developed countries.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

In-vitro fertilization market segmentation is as follows:

Biopharmaceuticals specializing in the in-vitro fertilization market are Boston IVF, Cook Medical, Inc., Cooper Surgical, Inc., EMD Serono, Inc., Genea Biomedx, Irvine Scientific, Inc., OvaScience, Inc., Progyny, Inc., Thermo Fisher Scientific, Inc., and Vitrolife AB.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key questions are answered in this report.

  • Which major players are providing culture media and disposable devices related to in vitro fertilization treatment?
  • What are the latest treatment protocols adopted for in vitro fertilization?
  • Which factors are responsible for the rising prevalence of infertility throughout the world?
  • What will be the size of the market for disposable devices in the near future?
  • Why is fresh non-donor the leading type segment in the in-vitro fertilization market?
  • What will be the market performance of fertility clinics and hospitals during the forecast period?
  • What is the treatment regimen adopted in developed regions such as Europe and North America?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global IVF Market Portraiture
2.2. Global IVF Market, by Instrument, 2017 (US$ Mn)
2.3. Global IVF Market, by Type, 2017 (US$ Mn)
2.4. Global IVF Market, by End User, 2017 (US$ Mn)
2.5. Global IVF Market, by Geography, 2017 (US$ Mn)

Chapter 3. In-Vitro Fertilization (IVF) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global IVF Market, by Key Players, 2017

Chapter 4. Global In-Vitro Fertilization (IVF) Market, by Instrument
4.1. Overview
4.2. Disposable Devices
4.3. Culture Media
4.4. Capital Equipment

Chapter 5. Global In-Vitro Fertilization (IVF) Market, by Type
5.1. Overview
5.2. Fresh Donor
5.3. Frozen Donor
5.4. Fresh Non-Donor
5.5. Frozen Non-Donor

Chapter 6. Global In-Vitro Fertilization (IVF) Market, by End User
6.1. Overview
6.2. Fertility Clinics
6.3. Hospitals

Chapter 7. Global In-Vitro Fertilization (IVF) Market, by Geography
7.1. Overview
7.2. North America IVF Market Analysis, 2016 – 2026
7.2.1. North America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.2.2. North America IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.2.3. North America IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.2.4. North America IVF Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe IVF Market Analysis, 2016 – 2026
7.3.1. Europe IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.3.2. Europe IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.3.3. Europe IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.3.4. Europe IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific IVF Market Analysis, 2016 – 2026
7.4.1. Asia Pacific IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America IVF Market Analysis, 2016 – 2026
7.5.1. Latin America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.5.2. Latin America IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.5.3. Latin America IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.5.4. Latin America IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East and Africa IVF Market Analysis, 2016 – 2026
7.6.1. MEA IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.6.2. MEA IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.6.3. MEA IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.6.4. MEA IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Boston IVF
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Cook Medical, Inc.
8.3. Cooper Surgical, Inc.
8.4. EMD Serono, Inc.
8.5. Genea Biomedx
8.6. Irvine Scientific, Inc.
8.7. OvaScience, Inc.
8.8. Progyny, Inc.
8.9. Thermo Fisher Scientific, Inc.
8.10. Vitrolife AB

List of Figures

FIG. 1 In-Vitro Fertilization (IVF) Market: Research Methodology
FIG. 2 IVF: Market Segmentation
FIG. 3 Global IVF Market, by Instrument, 2017 (US$ Mn)
FIG. 4 Global IVF Market, by Type, 2017 (US$ Mn)
FIG. 5 Global IVF Market, by End User, 2017 (US$ Mn)
FIG. 6 Global IVF Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: by Geography, 2017
FIG. 8 Competitive Analysis: Global IVF Market, by Key Players, 2017
FIG. 9 Global Disposable Devices Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 10 Global Culture Media Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 11 Global Capital Equipment Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 12 Global Fresh Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 13 Global Frozen Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 14 Global Fresh Non-Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 15 Global Frozen Non-Donor Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 16 Global Fertility Clinics Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 17 Global Hospitals Market for IVF, 2016 – 2026 (US$ Mn)
FIG. 18 U.S. IVF Market, 2016 – 2026 (US$ Mn)
FIG. 19 Canada IVF Market, 2016 – 2026 (US$ Mn)
FIG. 20 U.K. IVF Market, 2016 – 2026 (US$ Mn)
FIG. 21 Germany IVF Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Europe IVF Market, 2016 – 2026 (US$ Mn)
FIG. 23 China IVF Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan IVF Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific IVF Market, 2016 – 2026 (US$ Mn)
FIG. 26 Brazil IVF Market, 2016 – 2026 (US$ Mn)
FIG. 27 Mexico IVF Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Latin America IVF Market, 2016 – 2026 (US$ Mn)
FIG. 29 GCC IVF Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of MEA IVF Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global In-Vitro Fertilization (IVF) Market Portraiture
TABLE 2 Global IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 3 Global IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global IVF Market , by End User, 2016 – 2026 (US$ Mn)
TABLE 5 Global IVF Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 7 North America IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 9 North America IVF Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 11 Europe IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Europe IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 13 Europe IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa IVF Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa IVF Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 26 Boston IVF: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Cooper Surgical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Genea Biomedx: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Irvine Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 OvaScience, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Progyny, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Vitrolife AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions

What is the size of In-Vitro Fertilization Market?

The market for In-Vitro Fertilization Market is expected to reach US$ 36,854.0 Mn in 2026.

What is the In-Vitro Fertilization Market CAGR?

The In-Vitro Fertilization Market is expected to see significant CAGR growth over the coming years, at 10.1%.

What is the Forecast period considered for In-Vitro Fertilization Market?

The base year of this report is 2017.

The base year of this report is 2017.

Cooper Surgical, Inc., EMD Serono, Inc., Genea Biomedx, Irvine Scientific, Inc., OvaScience, Inc., Progyny, Inc., Thermo Fisher Scientific, Inc are some of the major players in the global market.

Animal Drug Compounding Market

Published:
Report ID: 40870

Antibiotics Market

Published:
Report ID: 40728

Conjugation and Labeling Services Market

Published:
Report ID: 40756

Antiviral Drugs Market

Published:
Report ID: 40681

Intravitreal Injectable Market

Published:
Report ID: 7250

Pharmacogenomics Market

Published:
Report ID: 9486

Nosocomial Infection Treatment Market

Published:
Report ID: 14189

Anti-Cancer Drugs Market

Published:
Report ID: 39971

Vial Adaptors for Reconstitution Drug Market

Published:
Report ID: 15561

Congenital Disabilities Market

Published:
Report ID: 39845

Acquired Hemophilia Treatment Market

Published:
Report ID: 1124

Tyrosine Kinase Inhibitors (TKIs) Market

Published:
Report ID: 39696

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN